ChiCTR2100054237 版本V1.9 版本创建时间2024/10/31 17:04:31 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100054237 

最近更新日期:

Date of Last Refreshed on:

2024-10-31 11:51:27 

注册时间:

Date of Registration:

2021-12-11 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

下腔静脉塌陷指数导向补液对全麻诱导后血流动力学的影响

Public title:

The effect of inferior vena cava collapse index-guided fluid supplementation on hemodynamics after induction of general anesthesia

注册题目简写:

English Acronym:

研究课题的正式科学名称:

下腔静脉塌陷指数导向补液对全麻诱导后血流动力学的影响

Scientific title:

The effect of inferior vena cava collapse index-guided fluid supplementation on hemodynamics after induction of general anesthesia

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

邱良诚 

研究负责人:

吴晓丹 

Applicant:

Qiu Liangcheng 

Study leader:

Wu Xiaodan 

申请注册联系人电话:

Applicant telephone:

+86 18046028248

研究负责人电话:

Study leader's
telephone:

+86 13055291720

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

119378547@qq.com

研究负责人电子邮件:

Study leader's E-mail:

wxiaodan@sina.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

福建省福州市仓山区金榕南路516号

研究负责人通讯地址:

福建省福州市鼓楼区东街134号

Applicant address:

516 Jinrong Road South, Cangshan District, Fuzhou, Fujian

Study leader's address:

134 East Street, Gulou District, Fuzhou, Fujian

申请注册联系人邮政编码:

Applicant postcode:

350001

研究负责人邮政编码:

Study leader's postcode:

350001

申请人所在单位:

福建省立医院麻醉科

Applicant's institution:

Fujian Provincial Hospital

研究负责人所在单位:

福建省立医院

Affiliation of the Leader:

Fujian Provincial Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

K2021-07-040

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

福建省立医院伦理委员会

Name of the ethic committee:

Ethics Committee of Fujian Provincial Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2021-07-29 00:00:00

伦理委员会联系人:

练发杨

Contact Name of the ethic committee:

Lian Fayang

伦理委员会联系地址:

福建省福州市鼓楼区东街134号

Contact Address of the ethic committee:

134 East Street, Gulou District, Fuzhou, Fujian

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

福建省立医院

Primary sponsor:

Fujian Provincial Hospital

研究实施负责(组长)单位地址:

福建省福州市鼓楼区东街134号

Primary sponsor's address:

134 East Street, Gulou District, Fuzhou, Fujian

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

福建

市(区县):

福州

Country:

China

Province:

Fujian

City:

Fuzhou

单位(医院):

福建省立医院

具体地址:

鼓楼区东街134号

Institution
hospital:

Fujian Provincial Hospital

Address:

134 East Street, Gulou District

经费或物资来源:

福建省立医院

Source(s) of funding:

Fujian Provincial Hospital

研究疾病:

围术期血流动力学  

Target disease:

Perioperative hemodynamics

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

研究全麻诱导前自主呼吸状态下腔静脉塌陷指数(IVC-CI)反映容量状态和容量反应性的可靠性;探讨诱导前IVC-CI导向输液是否可以降低诱导后低血压发生率。  

Objectives of Study:

To study the reliability of the vena cava collapse index (IVC-CI) in spontaneous breathing before general anesthesia induction to reflect volume status and volume responsiveness; to explore whether IVC-CI guided infusion before induction can reduce the incidence of hypotension after induction.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 拟在全麻下行择期手术的患者;
2. 自主呼吸的清醒患者;
3. 性别不限;
4. 年龄>18岁;
5. BMI<30 kg/m^2;
6. ASA I-II级;
7. 心功能I-II级;
8. 患者及其家属签署知情同意书。

Inclusion criteria

1. Patients who are planning to undergo elective surgery under general anesthesia;
2. Conscious patients who breathe spontaneously;
3. Gender is not limited;
4. Aged > 18 years;
5. BMI < 30 kg/m^2;
6. ASA Grade I-II;
7. Cardiac function I-II grade;
8. Patients and their families signed informed consent.

排除标准:

1. 外周血管疾病;
2. 严重的心血管疾病;
3. 腹内压增高;
4. 自主神经系统紊乱;
5. 困难气道;
6. 不能耐受补液治疗者;
7. 精神异常;
8. 有中心静脉置管和动脉穿刺禁忌症者;
9. B超下腔静脉显示不清者;
10. 超声测量IVCD,三个图像中的任意两个图像间IVCmax的差值超过0.2 cm;
11. 使用血管紧张素受体阻断剂或血管紧张素转换酶抑制剂;
12. 呼吸窘迫;
13. 诱导前平均动脉压(MAP)小于70 mmHg。

Exclusion criteria:

1. Peripheral vascular disease;
2. Severe cardiovascular disease;
3. Increased intra-abdominal pressure;
4. Autonomic nervous system disorder;
5. Difficult airway;
6. Those who cannot tolerate fluid replacement therapy;
7. Mental disorders;
8. Contraindications for central venous catheterization and arterial puncture;
9. B-ultrasonic inferior vena cava unclear display;
10. Ultrasound measurement of IVCD, between any two of the three images The difference of IVCmax exceeds 0.2 cm;
11. Use angiotensin receptor blockers or angiotensin converting enzyme inhibitors;
12. Respiratory distress;
13. Mean arterial pressure (MAP) before induction is less than 70 mmHg.

研究实施时间:

Study execute time:

From 2021-12-15 00:00:00 To 2022-08-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-12-15 00:00:00 To 2022-07-31 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

60

Group:

experimental group

Sample size:

干预措施:

IVC-CI导向输液

干预措施代码:

Intervention:

inferior vena cava collapse index-guided fluid supplementation

Intervention code:

组别:

对照组

样本量:

60

Group:

Control group

Sample size:

干预措施:

干预措施代码:

Intervention:

No

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

福建 

市(区县):

福州 

Country:

China

Province:

Fujian

City:

Fuzhou

单位(医院):

福建省立医院 

单位级别:

三级甲等 

Institution
hospital:

Fujian Provincial Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

下腔静脉塌陷指数

指标类型:

主要指标

Outcome:

Inferior vena cava collapse index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

No

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number table

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Not stated

Blinding:

Not stated

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

福建省立医院数据库,https://fjsl.com.cn/node/181.jspx

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Metadata of fujian provincial hospital, https://fjsl.com.cn/node/181.jspx

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

福建省立医院数据库

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Metadata of fujian provincial hospital

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-12-11 15:20:57